Romidepsin and Afatinib Abrogate Jak–Signal Transducer and Activator of Transcription Signaling and Elicit Synergistic Antitumor Effects in Cutaneous T-Cell Lymphoma
Bobby B. Shih(Cancer Genetics (United States)), Teresa Palomero(Columbia University Irving Medical Center)
Cited by 7
Related Papers
Activating mutations and translocations in the guanine exchange factor VAV1 in peripheral T-cell lymphomas
|Proceedings of the National Academy of Sciences|2017|118
Therapeutic targeting of the NOTCH1 and neddylation pathways in T cell acute lymphoblastic leukemia
|Proceedings of the National Academy of Sciences|2025|5